X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse AANJANEYA LIFECARE with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 DR. DATSONS LABS   ADCOCK INGRAM
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
ADCOCK INGRAM
Jun-14
DR. DATSONS LABS/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs126350-   
Low Rs31253-   
Sales per share (Unadj.) Rs133.0104.2-  
Earnings per share (Unadj.) Rs0.2-26.2-  
Cash flow per share (Unadj.) Rs6.6-21.8-  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs128.881.8-  
Shares outstanding (eoy) m31.66168.78-   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.62.9 20.3%   
Avg P/E ratio x516.1-11.5 -4,494.8%  
P/CF ratio (eoy) x11.8-13.9 -85.5%  
Price / Book Value ratio x0.63.7 16.5%  
Dividend payout %00-   
Avg Mkt Cap Rs m2,47750,869 4.9%   
No. of employees `000NA4.3 0.0%   
Total wages/salary Rs m563,193 1.8%   
Avg. sales/employee Rs ThNM4,095.3-  
Avg. wages/employee Rs ThNM743.7-  
Avg. net profit/employee Rs ThNM-1,031.9-  
INCOME DATA
Net Sales Rs m4,21117,581 23.9%  
Other income Rs m79123 63.9%   
Total revenues Rs m4,28917,704 24.2%   
Gross profit Rs m569-3,047 -18.7%  
Depreciation Rs m204759 26.9%   
Interest Rs m430476 90.3%   
Profit before tax Rs m13-4,159 -0.3%   
Minority Interest Rs m0-12 0.0%   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6260 2.3%   
Profit after tax Rs m5-4,430 -0.1%  
Gross profit margin %13.5-17.3 -77.9%  
Effective tax rate %48.0-6.2 -768.7%   
Net profit margin %0.1-25.2 -0.5%  
BALANCE SHEET DATA
Current assets Rs m6,85212,877 53.2%   
Current liabilities Rs m6,7117,245 92.6%   
Net working cap to sales %3.332.0 10.5%  
Current ratio x1.01.8 57.4%  
Inventory Days Days161111 145.0%  
Debtors Days Days318124 257.0%  
Net fixed assets Rs m3,6737,506 48.9%   
Share capital Rs m31782 387.9%   
"Free" reserves Rs m3,7610-   
Net worth Rs m4,07813,799 29.5%   
Long term debt Rs m1,6714,849 34.5%   
Total assets Rs m12,63326,068 48.5%  
Interest coverage x1.0-7.7 -13.3%   
Debt to equity ratio x0.40.4 116.6%  
Sales to assets ratio x0.30.7 49.4%   
Return on assets %3.4-15.2 -22.7%  
Return on equity %0.1-32.1 -0.4%  
Return on capital %7.7-19.8 -38.7%  
Exports to sales %22.90-   
Imports to sales %14.30-   
Net fx Rs m3570-   
CASH FLOW
From Operations Rs m1,3451,501 89.6%  
From Investments Rs m-2,256-461 489.5%  
From Financial Activity Rs m-1,2004,401 -27.3%  
Net Cashflow Rs m-2,1115,441 -38.8%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.83 Rs / ZAR

Compare DR. DATSONS LABS With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare DR. DATSONS LABS With: SHASUN PHARMA  NATCO PHARMA  GSK PHARMA  DR. REDDYS LAB  WOCKHARDT LTD.  



Today's Market

Weak Finish to the Week Post Vishal Sikka's Exit as CEO of Infosys(Closing)

Share markets in India witnessed selling pressure, led by slump in shares of Infosys Ltd. after Vishal Sikka resigned as chief executive officer of the country's second-largest software services exporter.

Related Views On News

Securities & Intelligence Services Ltd. (IPO)

Jul 31, 2017

Should you subscribe to the IPO of Securities & Intelligence Services Ltd?

Why Super Investors are Underperforming in This Market (The 5 Minute Wrapup)

Jul 8, 2017

If Super Investors can wait for the right pitch, so can you.

Tejas Networks Ltd. (IPO)

Jun 14, 2017

Should you subscribe to the IPO of Tejas Networks Ltd?

Discover the Secrets of Hidden Smallcaps From These AGMs (The 5 Minute Wrapup)

May 26, 2017

Don't be surprised to come across some Super Investors there!

A Trader's Nightmare. A Business Owner's Delight. (The 5 Minute Wrapup)

May 19, 2017

Not all small-cap investors see themselves as traders. Some see themselves as business owners.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS - NOVARTIS COMPARISON

COMPARE DR. DATSONS LABS WITH

MARKET STATS